Research Publication Ethics

This journal follows the recommendations of the International Committee of Medical Journal Editors (ICMJE, and the Korean Association of Medical Journal Editors ( in its review and handling procedures for all matters related to research ethics. This includes ethical regulations and issues such as plagiarism, duplicate publication, and research misconduct. Once recognized to have violated the research ethics regulations, author(s) should expect some actions to be taken. Author(s) may be subjected to warning, manuscript submission limitation, etc. And the editorial board may announce the fact to his/her institution and other relevant bodies. If the editorial board is not aware of the violations and the article has already been published, then a notice about this will probably be published with or without the author’s explanation or approval. And the Journal follows the COPE Flowcharts ( for resolving cases of suspected misconduct.

  • Research involving humans, or the use of human data must adhere to the principles of informed consent and undergo review and approval by an institutional review board (IRB). Human subjects research should be conducted in line with the Declaration of Helsinki. For experiments involving animals, the manuscript should indicate that the research has been reviewed by an international animal care and use committee (IACUC). When referring to patients, their identities should not be disclosed or abbreviated. In the case of submitting photographs of patients, their identities should be obscured. If there is even a possibility that the patient's identity could be revealed, written consent must be obtained.
  • Authors must meet all four of the following criteria, as recommended by the ICMJE: (1) Substantial contribution to the conception or design of the research; or acquisition, analysis, or interpretation of data (2) Writing the article or critically reviewing it for important intellectual content (3) Approval of the final version before publication (4) Responsibility for properly investigating and resolving issues related to the accuracy or veracity of the research. During the submission, review, and publication process of a manuscript, the corresponding author is primarily responsible for communicating with the journal and completing all documentation related to the submission process. This includes providing author details, research ethics review, clinical trial registration, and conflicts of interest information.
  • Disclosure of conflicts of interest: Authors should transparently disclose any potential conflicts of interest that could influence the outcome of the study. This includes financial relationships, personal relationships, research competitions, or intellectual interests. Even if the author believes that these factors have not influenced the writing of the paper, they should still be disclosed. Additionally, all sources of funding for the research should be clearly stated.
  • Researchers should have control over all stages of research design, including the analysis of results. However, they may choose not to publish a research paper if the funder has the right to control the publication of the author's research report.
  • Patient privacy and informed consent: In any form, a paper must not include personal information that could reveal the identity of a patient. However, if patient personal information is necessary for scientific purposes, it must be explained to the patient, parent, or family, and written 'informed consent' must be obtained before publication.
  • Principles on duplicate publication: No manuscript may be published if it is identical or similar to a manuscript already published or scheduled for publication elsewhere. Manuscripts published in this journal cannot be published in other journals, and multiple or duplicate publications can only be made if they meet the requirements specified in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Ann Intern Med 1997;126:36-47). However, abstract or poster presentations are not considered duplicate publications. If duplicate publications are discovered, authors may face penalties according to the rules of the journal.
Journal of Innovative Medical Technology
May 30, 2024 Vol.2 No.1, pp. 1~28

Most Keyword ?

What is Most Keyword?

  • It is most registrated keyword in articles at this journal during for 2 years.

Most View

Editorial Office